Aclarion, inc. announces filing of delayed 10-q quarterly report

Broomfield, co, aug. 25, 2023 (globe newswire) -- via newmediawire -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it was not able to file its quarterly report for the quarter ended june 30, 2023 by the august 21, 2023 extended filing deadline established by the securities and exchange commission. the company, therefore, is a late filer with respect to such report.
ACON Ratings Summary
ACON Quant Ranking